Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Amortization - Intangibles: 2016-2018

Historic Amortization - Intangibles for Ironwood Pharmaceuticals (IRWD) over the last 3 years, with Dec 2018 value amounting to $8.1 million.

  • Ironwood Pharmaceuticals' Amortization - Intangibles fell 38.90% to $1.2 million in Q3 2018 from the same period last year, while for Sep 2018 it was $11.6 million, marking a year-over-year increase of 91.90%. This contributed to the annual value of $8.1 million for FY2018, which is 30.53% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Amortization - Intangibles stood at $8.1 million for FY2018, which was up 30.53% from $6.2 million recorded in FY2017.
  • Over the past 5 years, Ironwood Pharmaceuticals' Amortization - Intangibles peaked at $8.1 million during FY2018, and registered a low of $981,000 during FY2016.
  • Over the past 3 years, Ironwood Pharmaceuticals' median Amortization - Intangibles value was $6.2 million (recorded in 2017), while the average stood at $5.1 million.
  • Data for Ironwood Pharmaceuticals' Amortization - Intangibles shows a peak YoY spiked of 533.44% (in 2017) over the last 5 years.
  • Over the past 3 years, Ironwood Pharmaceuticals' Amortization - Intangibles (Yearly) stood at $981,000 in 2016, then surged by 533.44% to $6.2 million in 2017, then spiked by 30.53% to $8.1 million in 2018.